CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $39,395,000 | -13.6% | 813,112 | -29.9% | 0.78% | -16.6% |
| Q2 2022 | $45,589,000 | +30.0% | 1,160,315 | +21.8% | 0.94% | +19.9% |
| Q1 2022 | $35,069,000 | -4.9% | 952,703 | +17.8% | 0.78% | +1.4% |
| Q4 2021 | $36,874,000 | -32.9% | 809,000 | -47.4% | 0.77% | -27.9% |
| Q3 2021 | $54,924,000 | +124.2% | 1,536,758 | +24.1% | 1.07% | +146.4% |
| Q2 2021 | $24,502,000 | -58.9% | 1,238,083 | -51.7% | 0.44% | -65.3% |
| Q1 2021 | $59,569,000 | +16.5% | 2,561,000 | +4.1% | 1.25% | +23.8% |
| Q4 2020 | $51,140,000 | – | 2,461,000 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |